AngioDynamics
ANGO
109 hedge funds and large institutions have $355M invested in AngioDynamics in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 10 closing their positions.
649% more call options, than puts
Call options by funds: $9.28M | Put options by funds: $1.24M
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
18% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 38
1% more funds holding
Funds holding: 108 → 109 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less capital invested
Capital invested by funds: $393M → $355M (-$38.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$4.03M |
| 2 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$3.57M |
| 3 |
QBFM
QS Batterymarch Financial Management
New York
|
+$1.99M |
| 4 |
BCM
BBT Capital Management
Fort Worth,
Texas
|
+$1.87M |
| 5 |
BC
Broadfin Capital
New York
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$9.58M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$3.25M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.22M |
| 4 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$1.98M |
| 5 |
Renaissance Technologies
New York
|
-$1.93M |
ANGO Hedge Fund Activity: Q1 2014 in Review
109 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2014, worth a combined $355M — down 9.8% from $393M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ANGO positions and 10 closed out — a net gain of 3 holders — while 45 added to existing stakes and 38 trimmed.
The largest buyer was Wells Fargo, adding an estimated $4.03M. The largest seller was Camber Capital Management, cutting an estimated $9.58M.
- 109 institutional investors held AngioDynamics (ANGO) as of Q1 2014, up from 108 in Q4 2013.
- Funds reported $355M of AngioDynamics stock for Q1 2014, down 9.8% quarter-over-quarter.
- 13 funds opened new AngioDynamics positions in Q1 2014 and 10 closed out, a net change of +3 holders.
- The largest AngioDynamics buyer in Q1 2014 was Wells Fargo, an estimated $4.03M added.
- The largest AngioDynamics seller in Q1 2014 was Camber Capital Management, an estimated $9.58M sold.
Based on aggregated 13F filings for Q1 2014.